Drug
SB 656933 clinical trials
Also written SB656933.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses SB 656933 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative ColitisTerminatedPhase 2GlaxoSmithKlineNCT00748410Written as SB-656933
- 28 Day Repeat Dose in Cystic Fibrosis PatientsCompletedPhase 2GlaxoSmithKlineNCT00903201Written as SB656933
- Repeat Dose Study in Male Healthy Volunteer SmokersCompletedPhase 1GlaxoSmithKlineNCT00615576Written as SB-656933
- SD Cystic Fibrosis StudyCompletedPhase 1GlaxoSmithKlineNCT00605761Written as SB656933